BioSpace News Archive

BrainCo’s prosthetic hand won Time Magazine’s Top 100 Inventions of the Year.

Helix BioPharma Corp., an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced the voting results of the Company’s annual and special meeting of shareholders held on December 6, 2019.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and purification, today announced that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”), has received State Licences for cannabis substances from the Department of Health and Human Services in Victoria, Australia

Founder and CEO of The iQ Group Global, Dr. George Syrmalis has been appointed as Chairman of the Board for GBS Inc., it was announced today.

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today the appointment of Kemal Malik, MB BS, to its Board of Directors

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, announced today that it will provide updates on its proprietary, neurology programs at the American Epilepsy Society (AES) Annual Meeting held in Baltimore, MD.

Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, announced that it has entered into a collaborative agreement with the Armed Forces Radiobiology Research Institute (AFRRI), part of the Uniformed Services University of the Health Sciences in Bethesda, MD, that conducts research in the field of radiobiology and related matters.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, will present the latest data on its antiepileptic drug (AED) cenobamate at the American Epilepsy Society (AES) 2019 Annual Meeting in Baltimore, Maryland (December 6 — 10, 2019).

MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, has conclusively defeated trademark infringement claims brought against 16 of its brands associated with online and print media, conferences and continuing medical education programs.

The Multiple Myeloma Research Foundation (MMRF) today announced that 34 abstracts will be presented at the 61st American Society of Hematology Annual Meeting in Orlando from December 7-10.